SCHEMBL7204411

SCHEMBL7204411

NCCNc1nccc(N)n1

nearest known ligand 0.55

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
CXCR4 P61073 1/20 0.55
SCN9A Q15858 8/20 0.45
HRH3 Q9Y5N1 1/20 0.42
FERMT2 Q96AC1 3/20 0.41
HRH4 Q9H3N8 2/20 0.40
ALDH1A1 P00352 1/20 0.40
KCNH2 Q12809 6/20 0.40
SCN5A Q14524 5/20 0.40
ALOX5AP P20292 1/20 0.38
FEN1 P39748 1/20 0.38
ZAP70 P43403 1/20 0.38
SYK P43405 1/20 0.38
CAMK2D Q13557 1/20 0.37
STK17A Q9UEE5 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
M-Xylene SCHEMBL27982228 0.86 SYK (0.50) CXCR4SCN9AKCNH2SCN5AZAP70
SCHEMBL11480039 0.83 SCN9A (0.44) CXCR4SCN9AHRH4ALDH1A1KCNH2
SCHEMBL28899507 0.80 TLR8 (0.57) SCN9AHRH3HRH4
SCHEMBL13034199 0.79 CXCR4 (0.54) CXCR4FERMT2ALDH1A1ZAP70SYK
SCHEMBL8133400 0.79 CXCR4 (0.54) CXCR4HRH3FERMT2HRH4ALDH1A1
SCHEMBL19477216 0.79 MKNK1 (0.50) SCN9AALDH1A1KCNH2SCN5A
SCHEMBL10188245 0.79 HRH4 (0.48) CXCR4SCN9AHRH3HRH4KCNH2
SCHEMBL11404764 0.78 PDPK1 (0.50) SCN9AHRH4KCNH2SCN5A
SCHEMBL15748924 0.78 SCN9A (0.40) CXCR4SCN9AHRH4KCNH2SCN5A
SCHEMBL15651573 0.78 HTR7 (0.56) HRH3HRH4ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0921122-B1 EPOXYSUCCINAMIDE DERIVATIVES OR SALTS THEREOF TAIHO PHARMACEUTICAL CO LTD (JP) 2003-05-21 EP disclosed
US-6110967-A USEFUL AS AGENTS FOR PREVENTING AND TREATING METABOLIC OSTEOPATHY SUCH AS OSTEOPOROSIS, HYPERCALCEMIA AND BONE METASTASIS OF CANCER BECAUSE THEY SPECIFICALLY INHIBITS CATHEPSIN L AND ITS FAMILY ENZYMES TO INHIBIT BONE RESORPTION TAIHO PHARMACEUTICALS CO., LTD. (JP) 2000-08-29 US disclosed
EP-0921122-A1 NOVEL EPOXYSUCCINAMIDE DERIVATIVES OR SALTS THEREOF TAIHO PHARMACEUTICAL COMPANY, LIMITED (JP) 1999-06-09 EP disclosed